April 1, 2020 | Lao Tribune

Daily Archives April 1, 2020

iTeos Therapeutics Closes $125 Million Series B2 Financing

iTeos Therapeutics Closes $125 Million Series B2 Financing   – Proceeds support advancing clinical development of next-generation cancer immunotherapies targeting A2A adenosine receptor and anti-TIGIT immune checkpoint – – Oversubscribed round co-led by new investors RA Capital Management and Boxer Capital – – New investors Janus Henderson Investors, RTW Investments and Invus also participated along with […]Read More

Philips enables hospitals and GPs to remotely screen and monitor ...

April 1, 2020 Philips provides healthcare institutions with telehealth solution to process high volume coronavirus-related healthcare requests via online screening, and supports healthcare providers in the use of external call centers to offer the correct care to patients If medically justified, patients infected with COVID-19 can be remotely monitored via automated questionnaires about their home […]Read More

33rd Electric Vehicle Symposium and Exposition scheduled for June ...

WASHINGTON, March 31, 2020 (GLOBE NEWSWIRE) — Siemens AG CEO Joe Kaeser and other key speakers, sponsors and exhibitors from the entire electric drive supply chain, including R&D experts, leading manufacturers, top industry executives and government partners, are slated to participate in the 33rd Electric Vehicle Symposium and Exposition (EVS33), scheduled for June 14 thru […]Read More

Radient Technologies Inc. Applies to Extend Warrants

EDMONTON, Alberta, March 31, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to extend the term of 1,070,712 warrants originally scheduled to expire on April 14, […]Read More

Radient Technologies Inc. Applies to Extend Warrants

EDMONTON, Alberta, March 31, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to extend the term of 1,070,712 warrants originally scheduled to expire on April 14, […]Read More